Social | RheumNow

Do your state have a pediatric rheumatologist? @ACRheum @ACRSimpleTasks #Act4Arthritis #rdam https://t.co/ZGvopF75lb

Howard Yang @HowardYangMD ( View Tweet )

6 years 10 months ago

FDA grants breakthrough status to OFEV (nintedanib) forthe treatment of chronic fibrosing interstitial lung diseases (ILDs), other than idiopathic pulmonary fibrosis (which it is currently approved for). Nintedanib has been studied in PSS ILD. https://t.co/K0ZTyqrfh6

Links:

http://bit.ly/2Mu4tcC

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

FDA has approved Taltz (ixekizumab) use in Active Ankylosing Spondylitis (Axial Spondyloarthritis). IXE previously approved for psoriasis & PsA. Recommended dose is 160 mg SC (two 80 mg injections) at Week 0, followed by 80 mg every 4 weeks. https://t.co/S8zwuYuK2H

Links:

Lilly Receives U.S. FDA Approval for Taltz® (ixekizumab) for the Treatment of A…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

CLE deserves a specialty approach, with more education and people (derms & Rheums) dedicated to it's managemment https://t.co/VDH4ksDRW4

Links:

NatRevRheumatol on Twitter: "#Septemberissue | Cutaneous lupus erythematos…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

@ClinRheumatol Whoa...this an 11 patient uncontrolled report - not a study and certainly NOT evidence that abatacept works in Sjogrens. ABA is not included in guidelines for, and not approved for use in Sjogrens. Journals who promote$$$ their publications should not be interpreting results!

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

PBMs: Driving Up Costs and Lowering Quality Care in America https://t.co/4gQr9L5Ate

Links:

PBMs: Driving Up Costs and Lowering Quality Care in America

ATAP @ATAPAdvocates ( View Tweet )

6 years 11 months ago

European Study of 24,195 axSpA pts shows that 1st TNFi resulted in 27% ASDAS inactive disease @6 months & 59% achieved BASDAI <40; 80% continued Rx after 1 year. 1178 patients w/ non-radiographic axSpA had lower 12-mos retention (73%) https://t.co/KJn5eD6wWw

Links:

Treatment response and drug retention rates in 24 195 biologic-naïve patients w…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

RheumNow Podcast is up! Upadacitinib Approved, ULT prevents erosions, JIA pregnancies, MDA-5 outcomes & more. Watch it here>> https://t.co/kzu32MMmRL or listen to the PODCAST on iTunes or SoundCloud>> https://t.co/Ewi3Kc6lta

Links:

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

https://t.co/Es3nquURHJ is my new website for Physicians and Patients interested in Still’s disease (systemic juvenile idiopathic arthritis), periodic fever syndromes and autoinflammatory diseases. Check out the cool AOSD Diagnosis Calculator!

Links:

StillsNow – An educational site for Physicians and Patients with Still&#0…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Day 2 of the NIH Symposium on Autoinflammatory and immune-dysregulatory Diseases - 90 World experts on IL-1 mediated autoinflammatory diseases, autoinflammatory Type-I interferonopathies, MAS/HLH, LIVE STREAMING here>> https://t.co/WQjtS1JJue

Links:

NIH VideoCast - Walter Reed-NIH Auto-Inflammatory Symposium 2019

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

RCT of 139 knee OA pts given either curcumin 500-mg tid or diclofenac 50-mg bid. At days 14 and 28 both had similar improvement in pain and KOOS score; but curcumin had better tolerance, less GI sxs and H2 blocker use. https://t.co/tcsDQWQOMg

Links:

Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a ran…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Retrospective review of US-guided Synovial Biopsies performed (clinical practice n=52, research n=12) - syn tissue obtained in 88%. Utility/impact was good (37% Dx impact, >95% PPV or NPV for infection & research 92% success. https://t.co/A7vzIHnKH1

Links:

Error - Cookies Turned Off

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Study of 1272 RA pts, 69.5% were seropositive. Seropositive RA patients had two-fold increased risk for abnormalities on PFTs (ORs ranging from 2.48 RLD, 3.12 COPD & 2.30 DLCO abnl; associations were stronger for RF+ than for CCP+. https://t.co/RQ5GgoGqwA

Links:

Association of rheumatoid arthritis-related autoantibodies with pulmonary funct…

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Thurs 8AM - start of the 2nd NIH Symposium on Autoinflammatory and immune-dysregulatory Diseases - World experts on IL-1 mediated autoinflammatory diseases, autoinflammatory Type-I interferonopathies, MAS/HLH, LIVE STREAMING AT 8AM EST https://t.co/XJ4EOIXyYm

Links:

https://buff.ly/2P4NkdT

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Retrospective review of temporal artery biopsies from Johns Hopkins Wilmer Eye institute from 2007-17 shows the adjusted incidence rate of Bx+ GCA was 3.1 (1.0-5.2) in blacks and 3.6 ( 2.5-4.7) per 100 000 white patients; higher in women (1.9x vs Men) https://t.co/MeO9cBqovg

Links:

https://buff.ly/30vUhG4

Dr. John Cush @RheumNow ( View Tweet )

6 years 11 months ago

Topics

Tweets

Do you get our email newsletter?